Accretion Nutraveda Limited

As of March 31, 2026, Accretion Nutraveda Limited carries a market capitalization of 1.51B, placing it among publicly traded companies globally. Its enterprise value stands at 1.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Accretion Nutraveda Limited has 7.24M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Accretion Nutraveda Limited maintains a current ratio of 11.98, meaning it holds 12.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

These figures are as of the close on October 12, 2026.

As of March 31, 2026, Accretion Nutraveda Limited holds 97.45M in cash and equivalents against 42.28M in total debt, resulting in a net debt position of -55.17M. Total book value stands at 354.73M, with working capital of 277.38M providing operational flexibility.